This New Medicare Pilot Program Offers GLP-1s For $50 A Month. Here’s What You Need To Know
Americans on Medicare can now purchase GLP-1s for just $50 a month thanks to a temporary pilot program called Bridge. ...
Sunday, July 12, 2026
Tag: Zepbound
How Eli Lilly Became a $1 Trillion Company
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster drug eventually faces competition. Here’s what ...
The Next Phase Of The Obesity Drug Race
Five years after Wegovy’s FDA approval, the obesity drug market has evolved rapidly. Novo Nordisk and Eli Lilly introduced GLP-1 ...
Why GLP-1s Are Helping The Hair Care Industry
Millions of Americans are taking GLP-1s and some of their side effects are creating new opportunities for the beauty industry. ...
Millions Of Americans Are Losing Weight With GLP-1s. Here’s How That’s Changing Retail.
Tens of millions of Americans are taking GLP-1 drugs, which cause rapid weight loss. Now, clothing retailers are expecting a ...
How Weight Loss Pills Could Reshape The GLP-1 Landscape
Injectable GLP-1s for obesity have been revolutionary products of the pharmaceutical industry over the past few years. Now, for the ...
Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available
Novo Nordisk President and CEO Mike Doustdar says Christmas has come early with US approval of its Wegovy weight loss ...
CVS drops Lilly’s Zepbound
CNBC's Angelica Peebles reports on news regarding CVS. source
rewrite this title FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
rewrite this content using a minimum of 1000 words and keep HTML tags The Food and Drug Administration has authorized ...
- Trending
- Comments
- Latest
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.